Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
DYNACIN (MINOCYCLINE)
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Natalizumab in relapsing-remitting multiple sclerosis.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Alteration of CD1 expression in multiple sclerosis.
The refinement of genetic predictors of multiple sclerosis.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
Daily hassles reported by Dutch multiple sclerosis patients.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Management of multiple sclerosis: An overview.
[Central motor pathways in children with multiple sclerosis].
Neuromyelitis optica: clinical manifestations and neuroimaging features.
Diffusion Tensor Imaging (DTI) - A New Imaging Technique Applyed in Multiple Sclerosis.
Multiple sclerosis: An old drug plays a new trick.
Pages
« first
‹ previous
…
152
153
154
155
156
157
158
159
160
…
next ›
last »